References Compliance Notice This product is intended for laboratory research use only and is not approved for human or veterinary use.
While BMI is a valuable tool, measures of central adiposity, such as waist circumference, provide additional insight into cardiometabolic risks
S.BaromhM
The results, published in Nature Medicine in June 2024, showed liver fat reductions that surpassed every other drug studied: Source: Sanyal et al., Nature Medicine 2024 An 82% reduction in liver fat in just 24 weeks is remarkable
The exenatide group in this study, however, showed a significant increase in the mean cardiac output by 1.2 L/min, a reduced total peripheral resistance by the mean of 120 dyns/cm 5 , and a significantly reduced urinary sodium: creatinine ratio without a significant change in the BP [39]
GLP-1 Access Options FuturHealth provides access to both compounded GLP-1 medications and name-brand options such as Wegovy and Ozempic